Ovarian PRP for Diminished Ovarian Reserve
NCT05790655
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Diminished Ovarian Reserve
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 35 to 42 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Generation Next Fertility
- Last updated on ClinicalTrials.gov
- February 13, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Generation Next Fertility · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.